Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Regeneron Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 1,309 institutions reported holding Regeneron Pharmaceuticals, Inc., 90.6% of its shares. Largest: Vanguard, BlackRock and Dodge & Cox. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Regeneron Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 10.9M | 10.7% | +1.44M | Aug 13, 2026 |
| BlackRock | 9.11M | 9.0% | +166K | Aug 7, 2026 |
| Dodge & Cox | 4.87M | 4.8% | +413K | Aug 13, 2026 |
| State Street | 4.83M | 4.8% | +170K | Aug 7, 2026 |
| Invesco | 3.94M | 3.9% | +2.22M | Aug 14, 2026 |
| JPMorgan | 3.77M | 3.7% | −538K | Aug 12, 2026 |
| Franklin Templeton | 2.84M | 2.8% | +39,612 | Aug 13, 2026 |
| Geode Capital | 2.63M | 2.6% | +18,078 | Aug 12, 2026 |
| Nuveen | 2.02M | 2.0% | −44,855 | Aug 11, 2026 |
| Loomis Sayles & Co L P | 1.86M | 1.8% | −53,138 | Aug 14, 2026 |